AAP Recommends Nirsevimab to Protect Infants Against Severe RSV: Monoclonal Antibody Gains Traction Dr. Kamal Kant Kohli18 Aug 2023 9:45 AM ISTUSA: The American Academy of Pediatrics (AAP) has released recommendations for the use of the monoclonal antibody nirsevimab for the prevention of...
AstraZeneca gets CDSCO Panel Nod To Import, Market Palivizumab solution for injection Dr. Divya Colin17 Aug 2023 6:00 PM ISTNew Delhi: Pharmaceutical major AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Sanofi-AstraZeneca Beyfortus gets unanimous US CDC Advisory Committee recommendation to prevent RSV in neonates, infants Ruchika Sharma4 Aug 2023 1:09 PM ISTParis: Sanofi has recently announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization...
RSV infection during infancy tied to onset of asthma in childhood: Lancet Aditi31 July 2023 8:00 PM ISTA study published in The Lancet has found an age-dependent association between respiratory syncytial virus or RSV infection during infancy and...
FDA approves new drug to Prevent RSV in infants and very young children Dr. Kamal Kant Kohli19 July 2023 11:45 AM ISTThe U.S. Food and Drug Administration has approved The FDA approved nirsevimab (Beyfortus) for prevention of respiratory syncytial virus (RSV)-related...
GSK gets CDSCO panel Nod for Phase III Extension safety follow-up study for trial of RSVPreF3 vaccine Dr. Divya Colin12 July 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted approval to the drug...
GSK RSV shot Arexvy approved in Britain for adults aged 60 years and older Ruchika Sharma10 July 2023 3:30 PM ISTBritain: Britain's health regulator approved GSK's vaccine for the respiratory syncytial virus (RSV), which causes thousands of hospitalisations and...
Moderna announces global regulatory submissions for respiratory syncytial virus vaccine Ruchika Sharma6 July 2023 12:30 PM ISTmRNA-1345 is an investigational RSV vaccine that consists of a single mRNA sequence encoding for a stabilized prefusion F glycoprotein.
CDC panel advises Respiratory syncytial virus vaccination for elders Jacinthlyn Sylvia23 Jun 2023 9:30 AM ISTThe newly authorized respiratory syncytial virus (RSV) vaccinations should be given to persons aged 60 to 64 and 65 and older, according to the...
AstraZeneca-Sanofi Nirsevimab unanimously recommended by USFDA Advisory Committee for prevention of RSV in infants Ruchika Sharma9 Jun 2023 1:30 PM ISTLondon: The US Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) has voted unanimously 21 to 0 that AstraZeneca and...
GSK gets European Commission nod for RSV vaccine Arexvy for older adults Ruchika Sharma7 Jun 2023 1:30 PM ISTRespiratory syncytial virus vaccine, adjuvanted, contains recombinant glycoprotein F stabilised in the prefusion conformation.
FDA approves first-ever vaccine against respiratory syncytial virus for elderly Dr. Kamal Kant Kohli5 May 2023 9:45 AM ISTUSA: The first vaccine against the respiratory syncytial virus has received US FDA's approval and is expected to be available for people aged 60 and...
